139 related articles for article (PubMed ID: 33122230)
21. Temozolomide treatment of an adult with a relapsing medulloblastoma.
Durando X; Thivat E; Gilliot O; Irthum B; Verrelle P; Vincent C; Bay JO
Cancer Invest; 2007 Sep; 25(6):470-5. PubMed ID: 17882660
[TBL] [Abstract][Full Text] [Related]
22. Invasive Basal Cell Carcinoma of the Skin Treated Successfully with Vismodegib: A Case Report.
Awad R; Andrade JCB; Mousa H; Mahmoud F
Perm J; 2018; 22():17-181. PubMed ID: 30005721
[TBL] [Abstract][Full Text] [Related]
23. Medulloblastoma in two successive pregnancies.
Razak AR; Nasser Q; Morris P; Alcutt D; Grogan L
J Neurooncol; 2005 May; 73(1):89-90. PubMed ID: 15933823
[TBL] [Abstract][Full Text] [Related]
24. A large-scale drug screen identifies selective inhibitors of class I HDACs as a potential therapeutic option for SHH medulloblastoma.
Pak E; MacKenzie EL; Zhao X; Pazyra-Murphy MF; Park PMC; Wu L; Shaw DL; Addleson EC; Cayer SS; Lopez BG; Agar NYR; Rubin LL; Qi J; Merk DJ; Segal RA
Neuro Oncol; 2019 Sep; 21(9):1150-1163. PubMed ID: 31111916
[TBL] [Abstract][Full Text] [Related]
25. Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449.
Rudin CM; Hann CL; Laterra J; Yauch RL; Callahan CA; Fu L; Holcomb T; Stinson J; Gould SE; Coleman B; LoRusso PM; Von Hoff DD; de Sauvage FJ; Low JA
N Engl J Med; 2009 Sep; 361(12):1173-8. PubMed ID: 19726761
[TBL] [Abstract][Full Text] [Related]
26. Complete and sustained response of adult medulloblastoma to first-line sonic hedgehog inhibition with vismodegib.
Lou E; Schomaker M; Wilson JD; Ahrens M; Dolan M; Nelson AC
Cancer Biol Ther; 2016 Oct; 17(10):1010-1016. PubMed ID: 27682250
[TBL] [Abstract][Full Text] [Related]
27. Design, Synthesis, and Structure-Activity Relationship of Tetrahydropyrido[4,3-d]pyrimidine Derivatives as Potent Smoothened Antagonists with in Vivo Activity.
Lu W; Liu Y; Ma H; Zheng J; Tian S; Sun Z; Luo L; Li J; Zhang H; Yang ZJ; Zhang X
ACS Chem Neurosci; 2017 Sep; 8(9):1980-1994. PubMed ID: 28618224
[TBL] [Abstract][Full Text] [Related]
28. The change in patterns of relapse in medulloblastoma.
Tarbell NJ; Loeffler JS; Silver B; Lynch E; Lavally BL; Kupsky WJ; Scott RM; Sallan SE
Cancer; 1991 Oct; 68(7):1600-4. PubMed ID: 1893359
[TBL] [Abstract][Full Text] [Related]
29. Recurrent extraneural sonic hedgehog medulloblastoma exhibiting sustained response to vismodegib and temozolomide monotherapies and inter-metastatic molecular heterogeneity at progression.
Petrirena GJ; Masliah-Planchon J; Sala Q; Pourroy B; Frappaz D; Tabouret E; Graillon T; Gentet JC; Delattre O; Chinot O; Padovani L
Oncotarget; 2018 Feb; 9(11):10175-10183. PubMed ID: 29515801
[TBL] [Abstract][Full Text] [Related]
30. Cerebellar medulloblastoma presenting with skeletal metastasis.
Barai S; Bandopadhayaya GP; Julka PK; Dhanapathi H; Haloi AK; Seith A
J Postgrad Med; 2004; 50(2):110-2. PubMed ID: 15235205
[TBL] [Abstract][Full Text] [Related]
31. Vismodegib and Physeal Closure in a Pediatric Patient.
Lucas JT; Wright KD
Pediatr Blood Cancer; 2016 Nov; 63(11):2058. PubMed ID: 26864592
[No Abstract] [Full Text] [Related]
32. Intrathecal chemotherapy delivered by a lumbar-thecal catheter in metastatic medulloblastoma: a case illustration.
Clayton J; Vloeberghs M; Jaspan T; Walker D; MacArthur D; Grundy R
Acta Neurochir (Wien); 2008 Jul; 150(7):709-12. PubMed ID: 18401539
[TBL] [Abstract][Full Text] [Related]
33. Vismodegib.
Rudin CM
Clin Cancer Res; 2012 Jun; 18(12):3218-22. PubMed ID: 22679179
[TBL] [Abstract][Full Text] [Related]
34. Secondary manifestation of medulloblastoma: metastases and local recurrences in 66 patients.
Sure U; Bertalanffy H; Isenmann S; Brandner S; Berghorn WJ; Seeger W; Aguzzi A
Acta Neurochir (Wien); 1995; 136(3-4):117-26. PubMed ID: 8748840
[TBL] [Abstract][Full Text] [Related]
35. [A patient with lung metastasis of medulloblastoma].
Naitoh T; Matsushita K; Asai Y; Suetsugu S
Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Nov; 34(11):1260-3. PubMed ID: 8976084
[TBL] [Abstract][Full Text] [Related]
36. Clinical experience with Hedgehog pathway inhibitors.
Low JA; de Sauvage FJ
J Clin Oncol; 2010 Dec; 28(36):5321-6. PubMed ID: 21041712
[TBL] [Abstract][Full Text] [Related]
37. Metastatic medulloblastoma at diagnosis.
Gupta S; Pant MC; Husain N; Sundar S
J Cancer Res Ther; 2011; 7(2):203-4. PubMed ID: 21768715
[TBL] [Abstract][Full Text] [Related]
38. Metastatic medulloblastoma in an adult; treatment with temozolomide.
Poelen J; Bernsen HJ; Prick MJ
Acta Neurol Belg; 2007 Jun; 107(2):51-4. PubMed ID: 17710841
[TBL] [Abstract][Full Text] [Related]
39. Differential patterns of metastatic dissemination across medulloblastoma subgroups.
Zapotocky M; Mata-Mbemba D; Sumerauer D; Liby P; Lassaletta A; Zamecnik J; Krskova L; Kyncl M; Stary J; Laughlin S; Arnoldo A; Hawkins C; Tabori U; Taylor MD; Bouffet E; Raybaud C; Ramaswamy V
J Neurosurg Pediatr; 2018 Feb; 21(2):145-152. PubMed ID: 29219788
[TBL] [Abstract][Full Text] [Related]
40. Expanded access study of patients with advanced basal cell carcinoma treated with the Hedgehog pathway inhibitor, vismodegib.
Chang AL; Solomon JA; Hainsworth JD; Goldberg L; McKenna E; Day BM; Chen DM; Weiss GJ
J Am Acad Dermatol; 2014 Jan; 70(1):60-9. PubMed ID: 24189279
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
